Clinical Trials Logo

Clinical Trial Summary

Reduction in size and number of oral premalignant lesions


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00036283
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 2
Start date November 2000
Completion date April 2004

See also
  Status Clinical Trial Phase
Completed NCT05215860 - Photographic Evidence of Oral Precancerous Lesions in Current Tobacco and Areca Nut Users Improves Their Quit Rates N/A
Completed NCT04153266 - Oral Epithelial Dysplasia Informational Needs Questionnaire
Completed NCT01752101 - Identification of a Plasma Proteomic Signature for Lung Cancer N/A
Completed NCT01752114 - Early Diagnosis of Pulmonary Nodules N/A
Completed NCT00314262 - Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor Phase 1/Phase 2
Completed NCT00179361 - Natural History of Oro-pharyngeal Cancer Precursors N/A
Recruiting NCT06165614 - Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya Phase 1
Not yet recruiting NCT01837693 - Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2 N/A
Completed NCT00043615 - Collection of Blood, Bone Marrow, Tumor or Tissue Samples N/A
Active, not recruiting NCT02158858 - A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis Phase 1/Phase 2
Completed NCT02323672 - Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions N/A
Completed NCT00851305 - Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy N/A
Not yet recruiting NCT04065737 - Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization Phase 2
Active, not recruiting NCT00655421 - Oral Cancer Screening in Mumbai, India by Primary Health Care Workers Phase 3
Completed NCT00213603 - Follow-up Modalities of Low Grade Precancerous Bronchial Lesions N/A
Completed NCT03100045 - Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3) Phase 1